Skip to main content

Advertisement

SpringerLink
Log in

Burden of Disease in Psoriatic Arthritis in Latin America: a Systematic Literature Review 

  • ORIGINAL ARTICLE
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction

Psoriatic arthritis is a chronic inflammatory pathology that generates a substantial and progressive deterioration of functionality and quality of life. It is associated with comorbidities (cardiovascular and metabolic) and involvement of mental health. In Latin America, information regarding the disease is limited. This study reviews the burden of disease (disease activity, functional involvement, clinical manifestations, comorbidities, patient-reported outcomes, quality of life, and use of health resources) in PsA patients in Latin America.

Methods

Systematic literature review of publications in PUBMED, EMBASE, Cochrane Database of Systematic Reviews–CDSR/Database of Abstracts of Reviews of Effects, LILACS, Scielo, Redalyc, conference abstracts, and grey literature. Two independent assessors selected studies and extracted information. Quality was assessed according to the type of study.

Results

We identified 692 references, selecting 50 studies: 41 cross-sectional, four economic-studies, four cohort studies and one systematic review. The information comes mainly from Brazil, Argentina, and Mexico. The estimated disease prevalence for Latin America ranges from 0.004 to 0.08% (95% CI 0.02–0.20). Measurements with validated instruments suggest suboptimal assessment of disease domains, significant functional compromise, loss of productivity, and high frequency of comorbidities, including mental health. Methodological and population considerations limit the generalizability of the findings.

Conclusions

The available information reports a considerable burden of disease in patients with PsA in Latin America, with involvement of quality of life associated with disability in relation to disease activity and its various manifestations. Future research and funding efforts should be aimed at generating more standardized information about the impact of PsA in the region.

Key Points

•The functional involvement related to disease activity, the impact on the quality of life, and the frequency of cardiometabolic and psychological comorbidities are remarkable in Latin American patients with PsA.

•The current synthesis offers an overview of the burden of disease (disease activity, functional involvement, clinical manifestations, comorbidities, patient-reported outcomes, quality of life, and use of health resources) in PsA patients in Latin America.

•Future research efforts and clinical strategies are required in order to generate standardized data on the patients and better estimate the burden of disease in the region.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. FitzGerald O, Ogdie A, Chandran V, Coates LC, Kavanaugh A, Tillett W et al (2021) Psoriatic arthritis. Nat Rev Dis Primer [Internet] [cited 2022 Jul 4];7(1):59. Available from: https://www.nature.com/articles/s41572-021-00293-y

  2. Geijer M, Alenius GM, André L, Husmark T, Larsson PT, Lindqvist U et al (2021) Health-related quality of life in early psoriatic arthritis compared with early rheumatoid arthritis and a general population. Semin Arthritis Rheum [Internet] [cited 2022 Jul 4];51(1):246–52. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0049017220303036

  3. Stolwijk C, van Onna M, Boonen A, van Tubergen A (2016) Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis. Arthritis Care Res 68(9):1320–1331

    Article  Google Scholar 

  4. Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D et al (2019) Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol [Internet] [cited 2022 Jul 4];80(1):251–265.e19. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0190962218321492

  5. Pedersen OBV, Svendsen AJ, Ejstrup L, Skytthe A, Junker P (2008) The occurrence of psoriatic arthritis in Denmark. Ann Rheum Dis [Internet] [cited 2022 Jul 4];67(10):1422–6. Available from: https://ard.bmj.com/lookup/doi/10.1136/ard.2007.082172

  6. Kaipiainen-Seppanen O (1996) Incidence of psoriatic arthritis in Finland. Rheumatology [Internet] [cited 2022 Jul 4];35(12):1289–91. Available from: https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/35.12.1289

  7. Soriano ER, Rosa J, Velozo E, Schpilberg M, Imamura PM, Diaz J et al (2011) Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology [Internet] 50(4):729–34. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L361468092&from=export

  8. Veale DJ, Fearon U (2018) The pathogenesis of psoriatic arthritis. Lancet Lond Engl 391(10136):2273–2284

    Article  CAS  Google Scholar 

  9. Van den Bosch F, Coates L (2018) Clinical management of psoriatic arthritis. Lancet Lond Engl 391(10136):2285–2294

    Article  Google Scholar 

  10. Coates LC, Orbai AM, Azevedo VF, Cappelleri JC, Steinberg K, Lippe R et al (2020) Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire. Health Qual Life Outcomes [Internet] [cited 2022 Jul 4];18(1):173. Available from: https://hqlo.biomedcentral.com/articles/10.1186/s12955-020-01422-z

  11. Ranza R, Alten R, Strand V, Sullivan E, Blackburn S, Tian H et al (2017) Delayed biologic switching among psoriatic arthritis (PSA) patients may result in poor health-related quality of life: Results from a multi-national survey including Latin America. Value Health [Internet] 20(9):A903. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L619024167&from=export

  12. Fakih O, Prati C, Wendling D, Verhoeven F (2021) World mortality of spondyloarthritis and inflammatory bowel diseases in 2015 and its evolution between 2001 and 2015. Arthritis Rheumatol [Internet] 73(SUPPL 9):1165–7. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L637273261&from=export

  13. Bautista-Molano W (2021) Treatment of psoriatic arthritis: challenges in Latin America. Reumatol Clin 17(6):307–308. https://doi.org/10.1016/j.reuma.2021.03.006

  14. Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Acosta-Felquer M, Armstrong AW et al (2016) Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol Hoboken NJ 68(5):1060–1071

    Article  Google Scholar 

  15. Gossec L, Cañete J, Orbai AM, Leung YY, Palominos P, Scrivo R et al (2019) Are there country differences in disease activity and life impact of psoriatic arthritis an analysis of 436 patients from 14 countries. Arthritis Rheumatol [Internet] 71:1984–7. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L633058474&from=export

  16. Elmamoun M, Eraso M, Anderson M, Maharaj A, Coates L, Chandran V et al (2020) International league of associations for rheumatology recommendations for the management of psoriatic arthritis in resource-poor settings. Clin Rheumatol 39(6):1839–1850

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Soriano ER, Zazzetti F, Alves Pereira I, Maldonado Cocco J, Feijó Azevedo V, Guerra G et al (2020) Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America. Clin Rheumatol 39(6):1859–1869

    Article  PubMed  Google Scholar 

  18. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLOS Med [Internet] [cited 2022 Jul 4];18(3):e1003583. Available from: https://dx.plos.org/10.1371/journal.pmed.1003583

  19. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C et al (2012) Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol [Internet] [cited 2022 Jul 4];65(9):934–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0895435612000790

  20. Clinical advances through research and information translation (CLARITY)CLARITY Group at McMaster University. Resources [Internet]. DistillerSR. [cited 2022 Jun 8]. Available from: https://www.evidencepartners.com/resources

  21. The Joanna Briggs Institute Critical Appraisal tools, for use in JBI Systematic Reviews (2017) Checklist for Economic Evaluations [Internet] [cited 2022 Jul 4]. Available from: https://jbi.global/sites/default/files/2019-05/JBI_Critical_Appraisal-Checklist_for_Economic_Evaluations2017_0.pdf

  22. Citera G, Bautista-Molano W, Peláez-Ballestas I, Azevedo VF, Perich RA, Méndez-Rodríguez JA et al (2021) Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis. Adv Rheumatol [Internet] [cited 2022 Apr 21];61(1):2. Available from: https://advancesinrheumatology.biomedcentral.com/articles/10.1186/s42358-020-00161-5

  23. Fernández-Ávila DG, Bernal-Macias S, Rincón D, Gutiérrez J (2019) Thu0665 Prevalence of rheumatic diseases in Colombia: an approach from Ministry of Health and Social Protection Data (sispro). Ann Rheum Dis [Internet] [cited 2022 Aug 8];78(Suppl 2):629–629. Available from: https://ard.bmj.com/content/78/Suppl_2/629.1

  24. Rodriguez-Amado J, Peláez-Ballestas I, Sanin LH, Esquivel-Valerio AJ, Burgos-Vargas R, Pérez-Barbosa L et al (2011) Epidemiology of rheumatic diseases. A community-based study in urban and rural populations in the state of Nuevo Leon, Mexico. J Rheumatol [Internet] 38(SUPPL. 86):9–14. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L361047379&from=export

  25. Alvarez-Nemegyei J, Peláez-Ballestas I, Sanin LH, Cardiel MH, Ramirez-Angulo A, Goycochea-Robles MV (2011) Prevalence of musculoskeletal pain and rheumatic diseases in the Southeastern Region of Mexico. A COPCORD-based community survey. J Rheumatol Suppl [Internet] [cited 2022 Aug 8];86:21–5. Available from: https://www.jrheum.org/content/86/21

  26. Barba-Gómez JF, Zolano-Orozco M, Guevara-Gutiérrez E, Briseño-Rodríguez G, Villanueva-Quintero G, Tlacuilo-Parra A et al (2021) Psoriatic arthritis in patients with psoriasis: a clinical-epidemiological study at a dermatology center in western Mexico. Australas J Dermatol 62(3):e366–e372

    Article  PubMed  Google Scholar 

  27. Carneiro JN, de Paula AP, Martins GA (2012) Psoriatic arthritis in patients with psoriasis: evaluation of clinical and epidemiological features in 133 patients followed at the University Hospital of Brasília. An Bras Dermatol [Internet] 87(4):539–44. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L365667201&from=export

  28. Cordovés Quintana S, Suárez González M, Solis Cartas U, Caballero González M, Muñoz BM (2015) Findings of inflammatory arthropathy in patients with psoriasis. Rev Cuba Reumatol 17(2):166–171

    Google Scholar 

  29. Gamonal SBL, Gamonal ACC, Brandão MAF, Junqueira LA, de Assis PM, Raposo NRB (2021) Prevalence of psoriatic arthritis among patients with plaque psoriasis: a Brazilian retrospective study. Sao Paulo Med J [Internet] 139(5):476–80. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2013495212&from=export

  30. Paniagua BA, Melo VL, Silvia M, Solari VE, Sa CF, Genero S et al (2015) Association between different factors and psoriatic arthritis in patients of the “Dr. Manuel M. Giménez” dermatological center in Resistencia, Chaco (Argentina). Rev Argent Rheumatol 26(1):31–5

    Article  Google Scholar 

  31. Buschiazzo E, Maldonado-Cocco JA, Arturi P, Citera G, Berman A, Nitsche A et al (2011) Epidemiology of spondyloarthritis in Argentina. Am J Med Sci [Internet] 341(4):289–92. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L51303663&from=export

  32. De Carvalho HMS, Bortoluzzo AB, Gonçalves CR, Da Silva JAB, Ximenes AC, Bértolo MB et al (2012) Gender characterization in a large series of Brazilian patients with spondyloarthritis. Clin Rheumatol [Internet] 31(4):687–95. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L51786932&from=export

  33. García-Kutzbach A, Montenegro A, Iraheta I, Bará C, Saénz R (2011) Epidemiology of spondyloarthropathies in Central America. Am J Med Sci [Internet] 341(4):295–7. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L51303664&from=export

  34. Gehlen M, Regis KC, Skare TL (2012) Demographic, clinical, laboratory and treatment characteristics of spondyloarthritis patients with and without acute anterior uveitis. Sao Paulo Med J [Internet] [cited 2022 Jul 4];130(3):141–4. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802012000300002&lng=en&tlng=en

  35. Sampaio-Barros PD (2011) Epidemiology of spondyloarthritis in Brazil. Am J Med Sci [Internet] 341(4):287–8. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L51299545&from=export

  36. Skare TL, Leite N, Bortoluzzo AB, Gonçalves CR, da Silva JAB, Ximenes AC et al (2012) Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients. Clin Exp Rheumatol [Internet] 30(3):351–7. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L365367783&from=export

  37. Skare TL, Bortoluzzo AB, Gonçalves CR, Braga Da Silva JA, Ximenes AC, Bértolo MB et al (2012) Ethnic influence in clinical and functional measures of Brazilian patients with spondyloarthritis. J Rheumatol [Internet] 39(1):141–7. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L364036525&from=export

  38. Toloza SMA, Valle-Oñate R, Espinoza LR (2011) Psoriatic arthritis in south and Central America. Curr Rheumatol Rep [Internet] 13(4):360–8. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L51413685&from=export

  39. Da Silva MRR, Dos Santos JBR, Almeida AM, Kakehasi AM, De Oliveira Junior HA, Álvares-Teodoro J et al (2018) Effectiveness and safety of anti-TNF in psoriatic arthritis patients in Brazil: a post-incorporation analysis. J Comp Eff Res [Internet] 7(10):989–1000. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L624302229&from=export

  40. Molina M, Bernam A, Sueldo R (2007) Influence of sociodemographic factors on disease activity, functional status and quality of life of patients with psoriatic arthritis [Internet]. Revista Argentina de Reumatología. [cited 2022 Jul 4]. Available from: http://revistasar.org.ar/revistas/2007/numero_2/articulos/art_original_influencia_factores.pdf

  41. Moraes FA, da Silva MRR, dos Santos JBR, Acurcio FA, Almeida AM, Kakehasi AM et al (2021) Health-related quality of life in psoriatic arthritis: findings and implications. Value Health Reg Issues [Internet] 26:135–41. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2014014266&from=export

  42. Oliveira Junior HA, Almeida AM, Acurcio FA, Santos JB, Kakehasi AM, Alvares J et al (2015) Profile of patients with rheumatic diseases undergoing treatment with anti-TNF agents in the Brazilian public health system (SUS), belo horizonte – MG. Braz J Pharm Sci [Internet] 51(3):709–20. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L607133710&from=export

  43. Toloza SMA, Vega-Hinojosa O, Chandran V, Onate RV, Espinoza LR (2012) Psoriasis and psoriatic arthritis in Peruvian aborigines: a report from the GRAPPA 2011 annual meeting. J Rheumatol [Internet] 39(11):2216–9. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L365982766&from=export

  44. Bautista-Molano W, Landewé RBM, Londoño J, Romero-Sanchez C, Valle-Oñate R, van der Heijde D (2016) Analysis and performance of various classification criteria sets in a Colombian cohort of patients with spondyloarthritis. Clin Rheumatol [Internet] 35(7):1759–67. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L607841282&from=export

  45. Castresana-Isla CJ, Chaves Chavarría F (1995) Psoriatic arthritis (an analysis of 55 patients). Rev Méd Costa Rica Centroam 69–75

  46. da Silva MRR, dos Santos JBR, Almeida AM, Guerra Júnior AA, Alvares Teodoro J, Acurcio FDA (2019) Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations. Expert Rev Clin Immunol [Internet] 15(8):879–87. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L628322008&from=export

  47. Da Silva Souza C, Goldenstein-Schainberg C, Alvarenga Anti Loduca Lima SM, Spelling Gormezano N, Ferreira Magalhães R, Ranza R (2022) Clinical specialty setting as determinant of management of psoriatic arthritis: a cross-sectional Brazilian study. J Clin Rheumatol [Internet] 28(3):120–5. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2017549110&from=export

  48. Faria RJ, Cordeiro FJR, dos Santos JBR, Alvares-Teodoro J, Guerra Júnior AA, Acurcio FDA, et al (2022) Conventional synthetic disease-modifying anti-rheumatic drugs for psoriatic arthritis: findings and implications from a patient centered longitudinal study in Brazil. Front Pharmacol [Internet] 13. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2016533598&from=export

  49. Gallino Yanzi J, Cerda O, Landi M, Zaffarana C, Schneeberger E, Kythera G (2016) Factors influencing differences between global assessment of disease activity by patient and physician in patients with psoriatic arthritis. Rev Argent Rheumatol 27(3):10–14

    Article  Google Scholar 

  50. Zazzetti F, Soriano ER, Rocio Gil D, Maldonado cocco J, Vega Morales D, Alves Pereira I, et al (2018) FRI0709-HPR Levels of satisfaction with psoriatic arthritis (PSA) treatment and associated alignment between rheumatologists and their patients across Latin America. In: Friday, 15 June 2018 [Internet]. BMJ Publishing Group Ltd and European League Against Rheumatism [cited 2022 Jul 4]. p 1803 2–1803. Available from: https://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2018-eular.5597

  51. Adeodato Ramos LM, Gomes KWP, de Saboia Mont’Alverne AR, Braga MV, Costa Vasconcelos AH, Rodrigues CEM (2021) High prevalence of metabolic syndrome in patients with psoriatic arthritis from Northeastern Brazil: association with traditional cardiovascular risk factors and biologic disease-modifying antirheumatic drugs. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis [Internet] 27(6):S186–92. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L633724640&from=export

  52. Zaffarana C, Schneeberger E, Gallino Yanzi J, Cerda O, Landi M, Kythera G (2017) Prevalence of obesity in a cohort of patients with psoriatic arthritis and associated factors. Rev Argent Rheumatol 28(2):19–25

    Article  Google Scholar 

  53. Cazenave T, Maldonado Cocco J, Kythira G (2011) Validation and cultural adaptation of an Argentine version of the PsAQoL quality of life questionnaire in patients with psoriatic arthritis. Rev Arg Reum 22(2):42–50

    Google Scholar 

  54. Gonçalves RSG, Heaney A, McKenna SP, Carvalho JB, Vidal MEL, de Brito MCM, et al (2021) Psoriatic Arthritis Quality of Life Questionnaire: translation, cultural adaptation and validation into Brazilian Portuguese language. Adv Rheumatol [Internet] 61(1). Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2010583157&from=export

  55. de Lima FBF, Abalem MF, Ruiz DG, Gomes BAF, de Azevedo MNL, Moraes HV, et al (2012) Prevalence of eye disease in Brazilian patients with psoriatic arthritis. Clinics [Internet] 67(3):249–53. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L364592416&from=export

  56. Lopes N, Romiti R, Pietri G, Howe T, Gilloteau I, Tian H, et al (2017) Assessing the economic and humanistic burden of psoriatic arthritis in Brazil. Value Health [Internet] 20(9):A940. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L619025825&from=export

  57. Palominos PE, Gossec L, Kreis S, Hinckel CL, da Silva Chakr RM, Moro ALD, et al (2018) The effects of cultural background on patient-perceived impact of psoriatic arthritis - a qualitative study conducted in Brazil and France. Adv Rheumatol Lond Engl [Internet] 58(1):33. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L625999419&from=export

  58. Santos-Moreno P, Gómez-De La Rosa F, Parra-Padilla D, Alvis-Zakzuk NJ, Alvis-Zakzuk NR, Carrasquilla-Sotomayor M, et al (2021) Frequency of health care resource utilization and direct medical costs associated with psoriatic arthritis in a rheumatic care center in Colombia. Psoriasis Targets Ther [Internet] 11:31–9. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2006866984&from=export

  59. Sueldo R, Sofia Garay L, Gonzalez Lucero L, Constanza Bertolaccini M, Maldonado R, Lucia Barbaglia A et al (2018) Work disability in psoriatic arthritis patients. In Wiley 111 River St, Hoboken 07030–5774, NJ, USA. Abstract presented at 2018 ACR/ARHP Annual Meeting

  60. da Silva MRR, Dos Santos JBR, Almeida AM, Alvares-Teodoro J, Acurcio FDA (2021) Economic evaluation of adalimumab versus etanercept for psoriatic arthritis in a Brazilian real-world model. Expert Rev Pharmacoecon Outcomes Res [Internet] 22(3):473–9. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2010452360&from=export

  61. da Costa IP, Bortoluzzo AB, Gonçalves CR, da Silva JAB, Ximenes AC, Bértolo MB et al (2015) Evaluation of performance of BASDAI (bath ankylosing spondylitis disease activity index) in a Brazilian cohort of 1492 patients with spondyloarthritis: data from the Brazilian registry of Spondyloarthritides (RBE). Rev Bras Reumatol 55:48–54

    Article  PubMed  Google Scholar 

  62. Papadimitropoulos M, Romiti R, Lobosco S, Haro JM, Brnabic A, Leonardi Reyes F et al (2019) Quality of life of individuals with psoriasis in Latin America. Value Health Reg Issues [Internet] 19:S81. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2003356998&from=export

  63. Scheinberg M, Conaghan PG, Alten R, Sullivan E, Blackburn S, Tian H, et al (2017) Psoriatic arthritis limits patients’ ability to contribute to society as part of the workforce: results from a multi-national survey including Latin America. Value Health [Internet] 20(9):A903. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L619024254&from=export

  64. Azevedo VF, Conaghan PG, Strand V, Sullivan E, Blackburn S, Tian H, et al (2017) Appropriate psoriatic arthritis treatment is delayed for years: results from a multi-national survey including Latin America. Value Health [Internet] 20(9):A901. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L619024021&from=export

  65. Da Silva MRR, Dos Santos JBR, Almeida AM, Alvares-Teodoro J, Kakehasi AM, Acurcio FDA (2019) Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation. Adv Rheumatol [Internet] 59(1). Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L629849617&from=export

  66. Afanador Echeverri GF, Ribero V, Abdul F, Gis P (2019) PMU24 budget impact of secukinumab for the treatment of moderate-to-severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis from the Colombian healthcare perspective. Value Health [Internet] 22:S253. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2002154957&from=export

  67. Aiello E, Bianculli PM, Bhattacharyya D, Gunda P, Citera G (2019) Cost-effectiveness of secukinumab versus other biologics in the treatment of psoriatic arthritis: an Argentinean perspective. Value Health Reg Issues [Internet] 20:86–94. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2001970050&from=export

  68. González-Vacarezza N, Bertoldi EG, Deminco A, González G, Martínez Asuaga M (2014) Cost-utility analysis of using adalimumab, etanercept and infliximab for the treatment of psoriatic arthritis in Uruguay. Value Health Reg Issues [Internet] 5:58–64. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L607916475&from=export

  69. Pittam B, Gupta S, Harrison NL, Robertson S, Hughes DM, Zhao SS (2020) Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis. Rheumatology 59(9):2199–2206

    Article  PubMed  Google Scholar 

  70. Gupta S, Syrimi Z, Hughes DM, Zhao SS (2021) Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int 41(2):275–284

    Article  PubMed  PubMed Central  Google Scholar 

  71. Loganathan A, Kamalaraj N, El-Haddad C, Pile K (2021) Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis. Int J Rheum Dis 24(9):1112–1120

    Article  PubMed  Google Scholar 

  72. Yuan Z, Guo Y (2022) Risk of incident type 2 diabetes in patients with psoriatic arthritis: a systematic review and meta‐analysis of cohort studies. Int J Rheum Dis 25(9):1029–1037. https://doi.org/10.1111/1756-185X.14375

  73. Cañete JD, Tasende JAP, Laserna FJR, Castro SG, Queiro R (2020) The impact of comorbidity on patient-reported outcomes in psoriatic arthritis: a systematic literature review. Rheumatol Ther 7(2):237–257

    Article  PubMed  PubMed Central  Google Scholar 

  74. Zhao SS, Miller N, Harrison N, Duffield SJ, Dey M, Goodson NJ (2020) Systematic review of mental health comorbidities in psoriatic arthritis. Clin Rheumatol 39(1):217–225

    Article  PubMed  Google Scholar 

  75. Zusman EZ, Howren AM, Park JY, Dutz J, De Vera MA (2020) Epidemiology of depression and anxiety in patients with psoriatic arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 50(6):1481–1488. https://doi.org/10.1016/j.semarthrit.2020.02.001

  76. Zardin-Moraes M, da Silva ALFA, Saldanha C, Kohem CL, Coates LC, Henrique LR et al (2020) Prevalence of psoriatic arthritis patients achieving minimal disease activity in real-world studies and randomized clinical trials: systematic review with metaanalysis. J Rheumatol 47(6):839–846

    Article  PubMed  Google Scholar 

  77. Tillett W, de-Vries C, McHugh NJ (2012) Work disability in psoriatic arthritis: a systematic review. Rheumatology [Internet] [cited 2022 Jul 4];51(2):275–83. Available from: https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/ker216

  78. Kristensen LE, Jørgensen TS, Christensen R, Gudbergsen H, Dreyer L, Ballegaard C, et al (2017) Societal costs and patients’ experience of health inequities before and after diagnosis of psoriatic arthritis: a Danish cohort study. Ann Rheum Dis [Internet] [cited 2022 Jul 4];76(9):1495–501. Available from: https://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2016-210579

Download references

Author information

Authors and Affiliations

  1. Rheumatologist University Hospital Fundación Santa Fe de Bogotá, School of Medicine Universidad El Bosque, School of Medicine Universidad Militar Nueva Granada, Bogotá, Colombia

    Wilson Bautista-Molano

  2. Epidemióloga, MPH, InValue Health Solutions, Bogotá, Colombia

    Linda Ibatá & Susan Martínez

  3. Chemistry Pharmaceutical Epidemiologist, InValue Health Solutions, Bogotá, Colombia

    Andrea Chacón

Authors
  1. Wilson Bautista-Molano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linda Ibatá
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrea Chacón
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wilson Bautista-Molano.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 298 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bautista-Molano, W., Ibatá, L., Martínez, S. et al. Burden of Disease in Psoriatic Arthritis in Latin America: a Systematic Literature Review . Clin Rheumatol 43, 677–693 (2024). https://doi.org/10.1007/s10067-023-06838-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-023-06838-8

Keywords

Search

Navigation